Today: 9 June 2026
Browse Category

NASDAQ:SEED 15 October 2025

Origin Agritech’s SEED Stock Skyrockets 92% on China Seed Breakthroughs & Trade Buzz

Origin Agritech’s SEED Stock Skyrockets 92% on China Seed Breakthroughs & Trade Buzz

Origin Agritech (NASDAQ: SEED) surged 92% in after-hours trading on Oct. 14, then fell back near $1.43 by Oct. 15. The Beijing agri-tech firm re-entered Northeast China, showcased new hybrid corn seeds, and announced a partnership with Fengtian Seed Industry. CEO Weibin Yan invested $2.4 million in September, with institutions adding $1.48 million. The stock spike followed U.S.-China trade tensions that lifted agriculture shares.
15 October 2025
·
ASX:COOT TRIPLES AS TRADE WAR TALK IGNITES AGRI STOCK RALLY

ASX:COOT TRIPLES AS TRADE WAR TALK IGNITES AGRI STOCK RALLY

Australian Oilseeds (COOT) stock soared over 300% from $0.97 to about $4.00 in early trading Oct. 15, following U.S. President Trump’s threat to cut cooking oil imports from China. Trading volume spiked from 170,000 to 85 million shares. The rally spread to peers Origin Agritech and Arcadia Biosciences, which also posted large after-hours gains. COOT recently regained Nasdaq compliance and expanded its China market presence.
15 October 2025
···

Stock Market Today

  • Live Cattle Futures Drop as Wholesale Beef Prices Fall
    June 9, 2026, 12:14 PM EDT. Live cattle futures fell sharply on Monday, with August 2026 contracts down $4.93 at $236.73. Feeder cattle futures also declined, dropping $3.20 for August 2026 contracts. Wholesale boxed beef prices decreased, with Choice boxes down 50 cents to $392.20 and Select boxes falling $4.60 to $378.09. USDA estimated federally inspected cattle slaughter at 102,000 head, down 2,000 from the previous week and nearly 10,000 below last year. Calf prices showed mixed trends with steers down $10 and heifers up $2-8 at the Oklahoma City feeder cattle auction. Pasture conditions improved slightly to 31% rated good to excellent. Reports of New World Screwworm, a parasitic insect, emerged in Texas and New Mexico, potentially impacting cattle health.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
Go toTop